Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for HCmed Innovations Co., Ltd. (6934:TWSE), powered by AI.
HCmed Innovations Co., Ltd. is currently trading at $83.10. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for HCmed Innovations Co., Ltd. on Alpha Lenz.
HCmed Innovations Co., Ltd.'s P/E ratio is -32.1.
“HCmed Innovations Co., Ltd. trades at a P/E of -32.1 (undervalued) with modest ROE of -32.2%. 3Y revenue CAGR of 37.9% highlights clear growth momentum.”
Ask for details →HCmed Innovations Co., Ltd. is a health technology company that specializes in the development, manufacturing, and sales of advanced handheld medical nebulizers. Its primary focus lies in providing vibrating mesh nebulizers, which are engineered to effectively deliver liquid medications to the lower respiratory tract. This technology serves patients with conditions such as chronic obstructive pulmonary disease, asthma, cystic fibrosis, and respiratory infections. HCmed Innovations extends its capabilities to pharmaceutical partners through contract development and manufacturing organization (CDMO) services for drug-specific nebulizer systems, supporting the design and optimization of inhalation therapies. By ensuring compatibility with various drug formulations and adhering to rigorous pharmacopoeia guidelines, the company plays a key role in the medical equipment and biotechnology sectors. HCmed Innovations has established a global footprint, distributing its products across the United States, Taiwan, Switzerland, Israel, and the United Kingdom, and bolsters its market significance by contributing to the advancement of respiratory care and precision drug delivery technology.
“HCmed Innovations Co., Ltd. trades at a P/E of -32.1 (undervalued) with modest ROE of -32.2%. 3Y revenue CAGR of 37.9% highlights clear growth momentum.”
Ask for details →HCmed Innovations Co., Ltd. (ticker: 6934) is a company listed on TWSE in the Healthcare sector (Medical Devices). Market cap is $2.5B.
The current price is 83.1 with a P/E ratio of -32.09x and P/B of 11.99x.
ROE is -32.16% and operating margin is -26.55%. Annual revenue is $142M.